Radiation Biodosimetry in Patients Treated With Total Body Irradiation (TBI)
MSKCC patients undergoing TBI as part of a hematopoietic stem cell transplant (HSCT) will
have blood drawn and urine collected for use in the validation and refinement of new methods
for rapid high-throughput radiation biodosimetry. These blood and urine samples will be
collected before, and at defined times after TBI. Blood sampling will occur in the same
manner that it does during routine patient care during HSCT.
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
To develop, validate and refine high-throughput platforms for radiation biodosimetry using cytogenetic, protein, metabolomic and gene expression assays.
conclusion of the study
Christopher Barker, MD
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
|Memorial Sloan-Kettering Cancer Center||New York, New York 10021|